An assessment of risk factors for the complexity of coronary artery disease using the SYNTAX score

Ryan TJ, Faxon DP, Gunnar RM, Kennedy JW, King SB 3d, Loop FD, et al. Guidelines for percutaneous transluminal coronary angioplasty. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Percutaneous Transluminal Coronary Angioplasty). Circulation. 1988;78:486–502.

Sianos G, Morel MA, Kappetein AP, Morice MC, Colombo A, Dawkins K, et al. The SYNTAX score: an angiographic tool grading the complexity of coronary artery disease. EuroIntervention. 2005;1:219–27.

Serruys PW, Morice MC, Kappetein AP, Colombo A, Holmes DR, For the SYNTAX Investigators, et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med. 2009;360:961–72.

Mohr FW, Rastan AJ, Serruys PW, Kappetein AP, Holmes DR, Pomar JL, et al. Complex coronary anatomy in coronary artery bypass graft surgery: impact of complex coronary anatomy in modern bypass surgery? Lessons learned from the SYNTAX trial after two years. J Thorac Cardiovasc Surg. 2011;141:130–40.

Kappetein AP, Feldman TE, Mack MJ, Morice MC, Holmes DR, Stãhle E, et al. Comparison of coronary bypass surgery with drug-eluting stenting for the treatment of left main and/or three-vessel disease: 3-year follow-up of the SYNTAX trial. Eur Heart J. 2011;32:2125–34.

Dortimer AC, Shenoy PN, Shiroff RA, Leaman DM, Babb JD, Liedtke AJ, Zelis R. Diffuse coronary artery disease in diabetic patients: fact or fiction? Circulation. 1978;57:133–6.

The BARI Investigators. Influence of diabetes on 5-year mortality and morbidity in a randomized trial comparing CABG and PTCA in patients with multivessel disease: the Bypass Angioplasty Revascularization Investigation (BARI). Circulation 1997;96:1761–9.

Verghese M, Bernard JG, Brent AW, Warren KL, James TW, Tilbury RT, et al. Outcomes in patients with diabetes mellitus undergoing percutaneous coronary intervention in the current era: a report from the Prevention of REStenosis with Tranilast and its Outcomes (PRESTO) trial. Circulation. 2004;109:476–80.

Celermajer DS, Sorensen KE, Spiegelhalter DJ, Georgakopoulos D, Robinson J, Deanfield JE. Aging is associated with endothelial dysfunction in healthy men years before the age-related decline in women. J Am Coll Cardiol. 1994;24:471–6.

Mendelsohn ME, Karas RH. The protective effects of estrogen on the cardiovascular system. N Engl J Med. 1999;340:1801–11.

Nakamura T, Ogita M, Ako J, Momomura S. Gender differences of plaque characteristics in elderly patients with stable angina pectoris: an intravascular ultrasonic radiofrequency data analysis. Int J Vasc Med. 2010. doi: 10.1155/2010/134692 .

Jacobs AK. Coronary revascularization in women in 2003; sex revisited. Circulation 2003;107:375–77.

Dodge JT, Brown BG, Bolson EL, Dodge HT. Lumen diameter of normal human coronary arteries: influence of age, sex, anatomic variation, and left ventricular hypertrophy or dilation. Circulation. 1992;86:232–46.

Roberts CS, Roberts WC. Cross-sectional area of the proximal portions of the three major epicardial coronary arteries in 98 necropsy patients with different coronary events. Relationship to heart weight, age and sex. Circulation. 1980;62:953–9.

Kornowski R, Lansky AJ, Mintz GS, et al. Comparison of men versus women in cross-sectional area luminal narrowing, quantity of plaque, presence of calcium in plaque, and lumen location in coronary arteries by intravascular ultrasound in patients with stable angina pectoris. Am J Cardiol. 1997;79:1601–5.

Inoue F, Yamaguchi S, Ueshima K, Fujimoto T, Kagoshima T, Uemura S, et al. Gender differences in coronary plaque characteristics in patients with stable angina: a virtual histology intravascular ultrasound study. Cardiovasc Interv Ther. 2010;25:40–5.

Baris N, Akdeniz B, Uyar S, Ozel E, Kirimli O, Badak O, et al. Are complex coronary lesions more frequent in patients with diabetes mellitus? Can J Cardiol. 2006;22:935–7.

Frans JTW, Lawrence HY, Silvio EI, Deborah AC, Janice AD, Eugene JB, et al. Detection of silent myocardial ischemia in asymptomatic diabetic subjects the DIAD study. Diabetes Care. 2004;27:1954–61.

Miller PF, Sheps DS, Bragdon EE, Herbst MC, Dalton JL, Hinderliter AL, et al. Aging and pain perception in ischemic heart disease. Am Heart J. 1990;120:22–30.

Matsuzaki M, Kita T, Mabuchi H, Matsuzawa Y, Nakaya N, Oikawa S, et al. Large scale cohort study of the relationship between serum cholesterol concentration and coronary events with low-dose simvastatin therapy in Japanese patients with hypercholesterolemia. Primary prevention cohort study of the Japan Lipid Intervention Trial (J-LIT). Circ J. 2002;66:1087–95.

Saito Y, Shirai K, Sasaki N, Shinomiya M, Yoshida S. Prognosis of hypercholesterolemic patients taking pravastatin for five years: the Chiba Lipid Intervention Program (CLIP) Study. J Atheroscler Thromb. 2002;9:99–108.

Nissen SE, Tuzcu EM, Schoenhagen P, Brown BG, Ganz P, Vogel RA, et al. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial. JAMA. 2004;291:1071–80.

Nissen SE, Nicholls SJ, Sipahi I, Libby P, Raichlen JS, Ballantyne CM, et al. Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial. JAMA. 2006;295:1556–65.

Takayama T, Hiro T, Yamagishi M, Daida H, Hirayama A, Saito S, Yamaguchi T, Matsuzaki M, et al. Effect of rosuvastatin on coronary atheroma in stable coronary artery disease: multicenter coronary atherosclerosis study measuring effects of rosuvastatin using intravascular ultrasound in Japanese subjects (COSMOS). Circ J. 2009;73:2110–7.

Mochizuki S, Björn D, Shimizu M, Ikewaki K, Yoshikawa M, Taniguchi I, et al. Valsartan in a Japanese population with hypertension and other cardiovascular disease (Jikei Heart Study): a randomised, open-label, blinded endpoint morbidity–mortality study. Lancet. 2007;369:1431–9.

Sawada T, Yamada H, Björn D, Matsubara H. Effects of valsartan on morbidity and mortality in uncontrolled hypertensive patients with high cardiovascular risks: KYOTO HEART Study. Eur Heart J. 2009;30:2461–9.

Hirohata A, Yamamoto K, Miyoshi T, Hatanaka K, Hirohata S, Yamawaki H, et al. Impact of olmesartan on progression of coronary atherosclerosis: a serial volumetric intravascular ultrasound analysis from the OLIVUS (impact of OLmesarten on progression of coronary atherosclerosis: evaluation by IntraVascular UltraSound) trial. J Am Coll Cardiol. 2010;55:976–82.

Anavekar NS, McMurray JJV, Velazquez EJ, Solomon SD, Kober L, Rouleau JL, et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med. 2004;351:1285–95.

Go AS, Chertow GM, Fan D, McCulloch CE, Hsu C. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351:1296–305.

Levey AS, Eckardt KU, Tsukamoto Y, Levin A, Coresh J, Rossert J, et al. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2005;67:2089–100.

Ninomiya T, Kiyohara Y, Kubo M, Tanizaki Y, Doi Y, Okubo K, et al. Chronic kidney disease and cardiovascular disease in a general Japanese population: the Hisayama Study. Kidney Int. 2005;68:228–36.

Kawamura Y, Morino Y, Nagaoka M, Matsukage T, Masuda N, Ikari Y. Impact of chronic kidney disease on clinical and angiographic results following implantation of sirolimus-eluting coronary stents. Cardiovasc Interv Ther. 2011;26:18–25.

Klein LW, Block P, Brindis RG, McKay CR, McCallister BD, Wolk M. Percutaneous coronary intervention in octogenarians in the American college of cardiology-national cardiovascular data registry: development of a nomogram predictive of in-hospital mortality. J Am Coll Cardiol. 2002;40:394–402.

Shaw JA, Kingwell BA, Walton AS, Cameron JD, Pillay P, Gatzka CD, Dart AM. Determinants of coronary artery compliance in subjects with and without angiographic coronary artery disease. J Am Coll Cardiol. 2002;39:1637–43.

Bell MR, Holmes DR Jr, Berger PB, Garratt KN, Bailey KR, Gersh BJ. The changing in-hospital mortality of women undergoing percutaneous transluminal coronary angioplasty. JAMA. 1993;269:2091–5.

Arnold AM, Mick MJ, Piedmonte MR, Simpfendorfer C. Gender differences for coronary angioplasty. Am J Cardiol. 1994;74:18–21.

Welty FK, Mittleman MA, Healy RW, Muller JE, Shubrooks SJ Jr. Similar results of percutaneous transluminal coronary angioplasty for women and men with postmyocardial infarction ischemia. J Am Coll Cardiol. 1994;23:35–9.

Bell MR, Grill DE, Garratt KN, Berger PB, Gersh BJ, Holmes DR Jr. Long-term outcome of women compared with men after successful coronary angioplasty. Circulation. 1995;91:2876–81.